Wattiaux R, Misquith S, Wattiaux-De Coninck S, Dubois F
Laboratoire de Chimie Physiologique, Facultés Universitaires Notre-Dame de la Paix, Namur, Belgium.
Biochem Biophys Res Commun. 1989 Jan 16;158(1):313-8. doi: 10.1016/s0006-291x(89)80214-1.
We have investigated the endocytosis by rat liver of asialofetuin coupled to [125I] tyramine cellobiose: [125I] TCASF. Subcellular distribution of radioactive compounds was established after differential and isopycnic centrifugation and by analysing the fractions by SDS electrophoresis. Labelling secondary lysosomes was performed by injecting rats with Triton WR 1339 four days before injecting the protein. Results show that after being associated with endosomes [125I] TCASF is recovered in organelles where they are subjected to a first degradation, the density of these organelles is practically not affected by Triton WR 1339 injection. Later the degradation products are associated with lysosomes whose density is markedly lowered by Triton WR 1339 treatment. These observations suggest that the first intracellular organelles where [125I] TCASF is subjected to digestion are distinct from the secondary lysosome population. This could be in agreement with the hypothesis that supposes that endosomes acquire enzymes from primary lysosomes before fusion with secondary lysosomes.
我们研究了大鼠肝脏对与[125I]酪胺纤维二糖偶联的去唾液酸胎球蛋白([125I]TCASF)的内吞作用。通过差速离心和等密度离心,并通过SDS电泳分析各组分,确定了放射性化合物的亚细胞分布。在注射蛋白质前四天给大鼠注射曲拉通WR 1339,以标记次级溶酶体。结果表明,[125I]TCASF与内体结合后,在经历首次降解的细胞器中被回收,这些细胞器的密度实际上不受曲拉通WR 1339注射的影响。随后,降解产物与溶酶体结合,其密度因曲拉通WR 1339处理而显著降低。这些观察结果表明,[125I]TCASF进行消化的首个细胞内细胞器与次级溶酶体群体不同。这可能与以下假设一致,即假设内体在与次级溶酶体融合之前从初级溶酶体获得酶。